AU2020102595A4 - Novel osteoconductive material composition and coating thereof. - Google Patents

Novel osteoconductive material composition and coating thereof. Download PDF

Info

Publication number
AU2020102595A4
AU2020102595A4 AU2020102595A AU2020102595A AU2020102595A4 AU 2020102595 A4 AU2020102595 A4 AU 2020102595A4 AU 2020102595 A AU2020102595 A AU 2020102595A AU 2020102595 A AU2020102595 A AU 2020102595A AU 2020102595 A4 AU2020102595 A4 AU 2020102595A4
Authority
AU
Australia
Prior art keywords
pass
coating
composition
material composition
operated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2020102595A
Inventor
Lekshmi Gangadhar
Renuka Devi Pothuraju
Teja Putti venkata Siva
Siva Sankar Sana
Abhishek Nalluri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sana Siva Sankar Dr
Gangadhar Lekshmi Dr
Pothuraju Renuka Devi Miss
Original Assignee
Sana Siva Sankar Dr
Gangadhar Lekshmi Dr
Pothuraju Renuka Devi Miss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sana Siva Sankar Dr, Gangadhar Lekshmi Dr, Pothuraju Renuka Devi Miss filed Critical Sana Siva Sankar Dr
Priority to AU2020102595A priority Critical patent/AU2020102595A4/en
Application granted granted Critical
Publication of AU2020102595A4 publication Critical patent/AU2020102595A4/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/32Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/425Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D7/00Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials
    • B05D7/14Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials to metal, e.g. car bodies
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C4/00Coating by spraying the coating material in the molten state, e.g. by flame, plasma or electric discharge
    • C23C4/12Coating by spraying the coating material in the molten state, e.g. by flame, plasma or electric discharge characterised by the method of spraying
    • C23C4/134Plasma spraying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/06Coatings containing a mixture of two or more compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/08Coatings comprising two or more layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2202/00Metallic substrate
    • B05D2202/10Metallic substrate based on Fe
    • B05D2202/15Stainless steel
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2202/00Metallic substrate
    • B05D2202/20Metallic substrate based on light metals
    • B05D2202/25Metallic substrate based on light metals based on Al
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2202/00Metallic substrate
    • B05D2202/30Metallic substrate based on refractory metals (Ti, V, Cr, Zr, Nb, Mo, Hf, Ta, W)
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D7/00Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials
    • B05D7/50Multilayers
    • B05D7/52Two layers

Abstract

The disclosed osteocondcutive material composition 1 is tailored to intensify the regeneration process. The grafts developed by the composition mentioned in the claims has proven to demonstrate expedited healing by promoting blood vessel in growth and bone formation phenomena. The proposed composition is applied over the implants 2 for accelerated regeneration and improved bio compatibility with the body fluids and tissues. Few bio-metals which were prone to corrosion and degradation are made to fit the needs by applying an coating 1, developed by the proposed material composition. The method and parameters of such is disclosed wherein a plasma spray technique is used in this invention. ......................... 1 -2 FIG. 1. FIG. 2. FIG. 3.

Description

......................... 1
-2
FIG. 1.
FIG. 2.
FIG. 3.
AUSTRALIA Patents Act 1990
COMPLETE SPECIFICATION INNOVATION PATENT
Novel osteoconductive material composition and coating thereof.
The following statement is a full description of this invention, including the best method of performing it known to us:
Novel osteoconductive material composition and coating thereof TECHNICAL FIELD
The present disclosure relates to a osteoconductive material composition and a coating produced therefore.
DEFINITION
In the present specification and claims the term "comprising" shall be understood to have a broad meaning similar to the term "including" and will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps. This definition also applies to variations on the term "comprising" such as "comprise" and "comprises".
BACKGROUND
Bone implants design and integration into the human and animal life forms is often a baffling and daunting phenomenon.
With rise in global population and accidents, there is a great need to accelerate the bone and tissue healing and regeneration processes. During the times of injury or other events, the implants are produced based on the targeted bone dimensions of the individuals.
Introducing a foreign element in living bodies must be meticulously engineered due to its critical aftereffects. The materials for scaffolds for human body implants should possess properties such as biological compatibility, corrosion resistance and should support tissue growth.
Ease of manufacturing, osteoconduction supportive and comparable bone stiffness has made metals as a promising implant material. However, on the contrary, most of the approved metals for biomedical applications have shown degradation due to corrosion when prolonged exposure to body fluids.
There are many metals based bio-compatible materials that were widely used in the biomedical fields such metals include Nickel- Ni; Titanium-Ti and few grades of stainless steels materials. Addressing the issue of the corrosion inhibition and promoting tissue regeneration phenomena are crucial.
The material design for improved tissue regeneration and coating of such on the implants are disclosed in the resent invention.
SUMMARY
To improve healing of injuries and bones fractures,metal based biomaterials are widely used. These metals often results in corrosion and degradation when exposed to body fluids for prolonged periods. Moreover,due to the structural differences between metallic implants and human bones, the healing time is more than expected in most cases.
The most powerful features of bone implant materials are corrosion resistance, biocompatibility, wear resistance, bone stiffness match, and enhanced bone growth. There are numerous materials and deposition techniques developed for biomedical applications especially in the areas of orthopedic and bone grafting.
To improve bone- implant interactions, a tailored coating material composition is required for enhanced osteointegration phenomena and should be an ideal coating material on the bone implants. The deposition of coatings such as hydroxyapatite Ca 1 O(PO4 )e (OH) 2 ) (HA), polycaprolactone (PCL), di-calcium phosphate CaHPO 4.2H 2 0 (CA) and oxides such as TiO 2 , A1 203 have been significantly researched.
In the present invention, an optimized coating composition constitutes a mixture of HA and CA; the coatings greatly improves specific bone in-growth and supports osteointegration. The most widely researched deposition techniques include sol-gel, electrodeposition & electrochemical coatings, thermal spray techniques such as high-velocity oxy-fuel-based deposition, plasma spraying.
Above all, suspension plasma spraying technique is selected for the present invention disclose. this method is opted for obtaining high surface area which promotes tissue regrowth and bone healing as well as good adhesion strength at the implant interface.
The in-lab synthesized powders or commercial grade powders are procured according to the need. Later, subjected to ball milling and the ball milled powder was sieved to remove coarse grained particles. About 8 g of the fine powder was mixed with 1 g of sodium hexametaphophate.
In the subsequent step, the stated mixture is ultrasonicated for 5 min to get a stable suspension for suspension plasma spraying. The nozzle diameter of spray gun is 0.8mm.
As disclosed in the above statement, the adhesion strength is promoted by customizing the coat layer with by adding fractions of titanium dioxide in the range 3 to 5.5%. a range of particle sizes are used to optimize implant bond strength.
For the second pass, the plasma plume is fed with the mixture of HA and CA.
One major factor for promoting healing and better interaction with other tissues is by improving the surface area of the coat layer. Nevertheless, a trade-of between surface area and adhesion strength has to be engineered for biomedical applications.
The Suspension precursor plasma spraying of hydroxyapatite HA and CA novel composition on the the interface biomedical implants. Defined proportions are disclosed in the claims.
Example 1:
In one experimental case study, the suspension of 62.5% of (HP, Caio(PO4) (OH) 2 ), and 44% of (CaHPO 4.2H 20) along with 3.5% of nano titania powder for first pass and 82% of (HP, Caio(PO4)e (OH) 2 ), and 18% of (CaHPO 4 .2H20) for second pass.
Example 2:
In another experiment, suspension of 76% of (HP, CaO(PO 4 )e (OH) 2 ), and 19.5% of (CaHPO4.2H 20) along with 4.5% of nano titania powder for first pass and 86% of (HP, Ca1O(PO 4 )e (OH) 2 ), and 14% of (CaHPO 4.2H 20) for second pass.
The plasma operating parameter and feed rates are also optimized after series of experiments.
The suspension precursor is made to flow through the spray gun of standard 0.8mm nozzle diameter.The spray is be operated at different powers and feed rates along with carrier gases.
During suspension from the spray gun enters the plasma plume and gets carried by the feed gas.The particles gets melted and traverses with high speed and hits the target and bonds to the Ti-6Al-4V and Stainless steel implants.
Several experiments were carried out with changes in processing parameters.
Example 1:
Suspension is plasma sprayed at distance of 80mm at a feed rate of 35 ml/min operated at power range of 28KW for the first pass and the feed rate is increased to 30 KW during the second pass at constant distance and carriers gases.
Example 2:
The suspension is prepared with greater loading capacity of 9 g of the fine HA and CA powders mixed with 1 g of sodium hexametaphophate. In the volume fractions as mentioned in the materials composition example 2. The feed rate is reduced to 30ml/min keeping the other variables same as above stated example. This is ideal for first pass as it results in dense and thick layer.
BRIEF DESCRIPTION OF DRAWINGS
The objects and features of the present invention, which are believed to be novel, are set forth with particularity in the appended claims. The present invention, both as to its organization and manner of operation, together with further objects and advantages, may best be understood by reference to the following description, taken in connection with the accompanying drawings, in which:
Fig 1 schematic illustration of the osteocondcutive coating layer on the substrate(biomedical implant)
Fig 2. illustrates the balled milled powder of the disclosed mixture composition by scanning electron microscopy at 0.2pm magnification.
Fig 3. illustrates a coated layer onto medical implants by scanning electron microscopy at 10pm magnification.
DETAILED DESCRIPTION
In fig 1. the coat layer 1 is a two component layer on the implant 2 the during first pass a composite mixture of HA and CA along with titanium dioxide. Whereas the second pass constitutes HA and CA exclusively.
The illustration as in fig1 the coat layer 1 need not be necessarily be a mixture of CA and HA it can also be a single elemental composition material either HA or CA respectively.
The substrate or base element 2 in fig 1. can be any metallic bio-material and need not be confined to metallic materials. The most commonly used implant materials are considered which include Titanium; nickel and few grades bio-compatible of stainless steels.
The Fig2. is an scanning electron microscopy image of the ball milled powder samples of the comprising of the base elements as stated for coat layer. The powder are thoroughly mixed in planetary ball milling. This step during processing is also used to reduce the particle size of the powder.
As in Fig3. which depicts the surface image of the coat layer on the implant produced by scanning electron microscopy. It is evident that the coat layer thus obtained is rough and porous.

Claims (5)

The claims defining the invention are as follows:
1. The material composition for biomedical implants, and the coating route along with its operating parameters are claimed in the present invention. The materials composition includes a mixture with various weight fractions which are bio-compatible and osteoconduction supportive in nature. Furthermore, it also catalyzes tissue growth. The disclosed composition is also effective as a coating layer on the metal based biomedical implants for hindering corrosion when exposed to body fluids.
2. The material as stated in claim 1, is a mixture which constitutes, 58% to 86% of (HP, Calo(PO4)6 (OH) 2 ), and 32% to 45% of (CaHPO 4 .2H 20) along with 3 to 5.5% of nano titania powder.
3. The material as claimed in claim 2, are materials in powder form and shows a uni-modal particle size distribution, whereas its claimed to the size regime from 1.5nm to 10pm.
4. The coating mentioned in the claim 1, is developed over the implant via suspension precursor plasma spraying. The coat produced shown a porous network framework architecture which is facilitates body fluid interaction.Two pass model is used for deposition, first pass is used to make a dense layer for better adhesion strength and second pass to improve porosity. As mentioned above, in first pass titania powder as claimed in claim 2 is used.
5. The operating parameters of the coating method as stated in claim 4, are as follows; for first pass: plasma plume is operated at 30KW power, 500 A current with spray distance of 85mm, suspension feed rate of 30 ml/min in Ar and H 2 gas environments at 50 and 8 nlpm. In case of second pass: plasma is operated at same environments as first pass and flow rates while other operating parameters are operated at deviation of ±8% to the first pass.
2 2020102595
FIG. 1.
FIG. 2.
10μm
FIG. 3.
AU2020102595A 2020-10-05 2020-10-05 Novel osteoconductive material composition and coating thereof. Ceased AU2020102595A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2020102595A AU2020102595A4 (en) 2020-10-05 2020-10-05 Novel osteoconductive material composition and coating thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2020102595A AU2020102595A4 (en) 2020-10-05 2020-10-05 Novel osteoconductive material composition and coating thereof.

Publications (1)

Publication Number Publication Date
AU2020102595A4 true AU2020102595A4 (en) 2020-11-26

Family

ID=73458069

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020102595A Ceased AU2020102595A4 (en) 2020-10-05 2020-10-05 Novel osteoconductive material composition and coating thereof.

Country Status (1)

Country Link
AU (1) AU2020102595A4 (en)

Similar Documents

Publication Publication Date Title
Tamayo et al. Additive manufacturing of Ti6Al4V alloy via electron beam melting for the development of implants for the biomedical industry
Cockerill et al. Porous zinc scaffolds for bone tissue engineering applications: A novel additive manufacturing and casting approach
Gu et al. In vitro studies of plasma-sprayed hydroxyapatite/Ti-6Al-4V composite coatings in simulated body fluid (SBF)
Vilardell et al. Cold spray as an emerging technology for biocompatible and antibacterial coatings: state of art
Xue et al. In vivo evaluation of plasma sprayed hydroxyapatite coatings having different crystallinity
US7998523B2 (en) Open-pore biocompatible surface layer for an implant, methods of production and use
KR950012753B1 (en) Medical material and for its preparation
Roşu et al. Deposition of titanium nitride and hydroxyapatite-based biocompatible composite by reactive plasma spraying
Saleh et al. Biodegradable/biocompatible coated metal implants for orthopedic applications
AU2003224334A1 (en) A dental or orthopaedic implant
Gkomoza et al. Microstructural investigation of porous titanium coatings, produced by thermal spraying techniques, using plasma atomization and hydride-dehydride powders, for orthopedic implants
Swain et al. Effect of surface roughness on titanium medical implants
Cao et al. Plasma‐sprayed hydroxyapatite coating on carbon/carbon composite scaffolds for bone tissue engineering and related tests in vivo
Bansal et al. Investigation of corrosion behavior and surface properties of plasma sprayed HA/Sr reinforced coatings on CoCr alloys
Mediaswanti et al. Sputtered hydroxyapatite nanocoatings on novel titanium alloys for biomedical applications
US5482731A (en) Method for bonding a calcium phosphate coating to stainless steels and cobalt base alloys for bioactive fixation of artificial implants
Gardon et al. Improved bonding strength of bioactive cermet Cold Gas Spray coatings
Ergün et al. Effect of acid passivation and H2 sputtering pretreatments on the adhesive strength of sol–gel derived Hydroxyapatite coating on titanium surface
AU2020102595A4 (en) Novel osteoconductive material composition and coating thereof.
Li et al. Characterization of plasma sprayed hydroxyapatite/ZrO2 graded coating
Fathi et al. Novel hydroxyapatite/niobium surface coating for endodontic dental implant
Kannan et al. Metallic implants-An approach for long term applications in bone related defects
Leeuwenburgh et al. Calcium phosphate coatings
Hadipour et al. Preparation and characterization of plasma-sprayed nanostructured-merwinite coating on Ti-6Al-4V
Alontseva et al. Manufacturing and Characterization of Tantalum Microplasma Coatings for Biomedical Application

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)
MK22 Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry